Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased ABCA1 activity protects against atherosclerosis.

Roshni R Singaraja1, Catherine Fievet, Graciela Castro

  • 1Centre for Molecular Medicine and Therapeutics, Children's and Women's Hospital, University of British Columbia, 950 West 28th Avenue, Vancouver, British Columbia V5Z 4H4, Canada.

The Journal of Clinical Investigation
|July 3, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment.

Molecular metabolism·2020
Same author

Electrothermal patches driving the transdermal delivery of insulin.

Nanoscale horizons·2020
Same author

Incretin combination therapy for the treatment of non-alcoholic steatohepatitis.

Diabetes, obesity & metabolism·2020
Same author

Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK.

Hepatology communications·2020
Same author

Microbiome Modulation of the Host Adaptive Immunity through Bile Acid Modification.

Cell metabolism·2020
Same author

Analysis of the association of MPO and MMP-9 with stroke severity and outcome: Cohort study.

Neurology·2020

Overexpressing the ATP-binding cassette transporter A1 (ABCA1) in mice reduced atherosclerosis. This cholesterol transporter enhanced high-density lipoprotein (HDL) function, leading to smaller lesions.

Area of Science:

  • Cardiovascular Biology
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • The ATP-binding cassette transporter A1 (ABCA1) is crucial for reverse cholesterol transport, mediating cholesterol efflux from macrophages.
  • Previous studies showed ABCA1 overexpression in mice mildly increases HDL levels and macrophage cholesterol efflux.

Purpose of the Study:

  • To investigate the impact of ABCA1 overexpression on the development of atherosclerosis.
  • To assess changes in cholesterol efflux and HDL particle function in the context of atherosclerosis.

Main Methods:

  • Human ABCA1 transgenic mice (BAC(+)) were crossed with apolipoprotein E-deficient (ApoE(-/-)) mice.
  • Atherosclerotic lesion development was compared between BAC(+)ApoE(-/-) mice and ApoE(-/-) mice.
  • Cholesterol efflux from isolated macrophages and HDL particle function were analyzed.

Related Experiment Videos

Main Results:

  • BAC(+)ApoE(-/-) mice exhibited significantly smaller and less complex atherosclerotic lesions compared to ApoE(-/-) mice.
  • Macrophages from BAC(+)ApoE(-/-) mice showed increased cholesterol efflux.
  • Despite a modest increase in plasma HDL cholesterol, HDL particles from BAC(+)ApoE(-/-) mice were more efficient cholesterol acceptors, correlated with increased phospholipid levels.

Conclusions:

  • ABCA1 overexpression significantly attenuates atherosclerosis development in a mouse model.
  • Enhanced HDL cholesterol acceptor capacity, linked to increased phospholipids, contributes to the protective effect of ABCA1 against atherosclerosis.